Fig. 4From: Quantitative clinical assessment of motor function during and following LSVT-BIG® therapyAverage i10MW (a) step, (b) stride and (c) swing times for CONHealth and PDLSVT subjects at each stage of therapy. PDLSVT subjects developed significantly faster step (p < 0.001), stride (p < 0.001), swing (p < 0.001), and double stance times (p < 0.037) following therapy. Black horizontal lines represent the mean of all PDLSVT subjects at each stage of therapy. (** p < 0.01, * p < 0.05 compared to baseline - Pre1)Back to article page